UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2

Genome Biology, 2022-12, Vol.23 (1), p.252-35, Article 252

2022

Volltextzugriff (PDF)

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

Nature communications, 2021-07, Vol.12 (1), p.4319-4319, Article 4319

2021

Volltextzugriff (PDF)

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

Human mutation, 2008-05, Vol.29 (5), p.617-622

2008

Volltextzugriff (PDF)

Expression inactivation of SMARCA4 by microRNAs in lung tumors

Human molecular genetics, 2015-03, Vol.24 (5), p.1400-1409

2015

Volltextzugriff (PDF)

Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models

Cancers, 2020-12, Vol.12 (12), p.3712

2020

Volltextzugriff (PDF)

MET-oncogenic and JAK2-inactivating alterations are independent factors that affect regulation of PD-L1 expression in lung cancer

Clinical cancer research, 2018-09, Vol.24 (18), p.4579-4587

2018

Volltextzugriff (PDF)

MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1

Cancer discovery, 2014-03, Vol.4 (3), p.292-303

2014

Volltextzugriff (PDF)

MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex

Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (37)

2021

Volltextzugriff (PDF)

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells

The Journal of biological chemistry, 2020-02, Vol.295 (7), p.2001-2017

2020

Volltextzugriff (PDF)

Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts

Cancer research (Chicago, Ill.), 2014-11, Vol.74 (21), p.5978-5988

2014

Volltextzugriff (PDF)

The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

EMBO molecular medicine, 2012-07, Vol.4 (7), p.603-616

2012

Volltextzugriff (PDF)

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer

Cell reports. Medicine, 2023-04, Vol.4 (4), p.101006-101006, Article 101006

2023

Volltextzugriff (PDF)

Epigenetic Events in Lung Cancer

Advances in Radiation Oncology in Lung Cancer, 2023, p.17-31

2023

Volltextzugriff (PDF)

Abstract 3277: SWI/SNF inactivation vulnerability

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3277-3277

2022

Volltextzugriff (PDF)

Abstract A35: MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1

Molecular cancer research, 2015-10, Vol.13 (10_Supplement), p.A35-A35

2015

Volltextzugriff (PDF)

Abstract 4479: Unveiling the relationship between the SWISNF chromatin remodeling complex and noncoding RNAs

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4479-4479

2016

Volltextzugriff (PDF)

Abstract 4479: Unveiling the relationship between the SWI/SNF chromatin remodeling complex and noncoding RNAs

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4479-4479

2016

Volltextzugriff (PDF)

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

EMBO molecular medicine, 2012-07

2012

Volltextzugriff (PDF)

Abstract 2477: Max inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2477-2477

2014

Volltextzugriff (PDF)

Abstract 4022: Inactivation of the tumor suppressor BRG1 in lung cancer: Influence on nuclear receptors and cell differentiation

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4022-4022

2011

Volltextzugriff (PDF)

Abstract 1134: Analysis of the tumor supressor role of BRG1 in lung cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1134-1134

2010

Volltextzugriff (PDF)

Exploring the Specific Needs of Persons with Multiple Sclerosis for mHealth Solutions for Physical Activity: Mixed-Methods Study

JMIR mHealth and uHealth, 2018-02, Vol.6 (2), p.e37-e37

2018

Volltextzugriff (PDF)

More Stamina, a Gamified mHealth Solution for Persons with Multiple Sclerosis: Research Through Design

JMIR mHealth and uHealth, 2018-03, Vol.6 (3), p.e51-e51

2018

Volltextzugriff (PDF)

Potential of Large Language Models in Health Care: Delphi Study

Journal of medical Internet research, 2024-05, Vol.26 (1), p.e52399

2024

Volltextzugriff (PDF)

National Health and Nutrition Survey 2018-19: methodology and perspectives

Salud pública de México, 2019-11, Vol.61 (6), p.917-923

2019

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(367)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

Expression inactivation of SMARCA4 by microRNAs in lung tumors

Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models

MET-oncogenic and JAK2-inactivating alterations are independent factors that affect regulation of PD-L1 expression in lung cancer

MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1

MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells

Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts

The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer

Epigenetic Events in Lung Cancer

Abstract 3277: SWI/SNF inactivation vulnerability

Abstract A35: MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1

Abstract 4479: Unveiling the relationship between the SWISNF chromatin remodeling complex and noncoding RNAs

Abstract 4479: Unveiling the relationship between the SWI/SNF chromatin remodeling complex and noncoding RNAs

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

Abstract 2477: Max inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1

Abstract 4022: Inactivation of the tumor suppressor BRG1 in lung cancer: Influence on nuclear receptors and cell differentiation

Abstract 1134: Analysis of the tumor supressor role of BRG1 in lung cancer

Exploring the Specific Needs of Persons with Multiple Sclerosis for mHealth Solutions for Physical Activity: Mixed-Methods Study

More Stamina, a Gamified mHealth Solution for Persons with Multiple Sclerosis: Research Through Design

Potential of Large Language Models in Health Care: Delphi Study

National Health and Nutrition Survey 2018-19: methodology and perspectives

Suchergebnisse filtern